Tuberculosis


  • Scientists Develop Inhaled TB Vaccine
    A new tuberculosis vaccine successfully tested at the University of North Carolina at Chapel Hill is easier to administer and store and just as effective as one commonly used worldwide. Scientists at the UNC School of Pharmacy led by Tony Hickey, PhD, vetted a dry powder ...More
    March 17, 2008 Posted in News
  • Eli Lilly Grants $4.4 Million to the WHO for MDR-TB Program Expansion
    INDIANAPOLIS and LONDON -- Today Eli Lilly and Company announced its four-year grant of $4.3 million to the World Health Organization (WHO) for scaling up its global capacity to manage multi-drug resistant tuberculosis (MDR-TB) programs. The grant covers four activities, ...More
    March 12, 2008 Posted in News
  • Confronting the Challenge of Antimicrobial Resistance
    Drug resistance is making many diseases increasingly difficult -- and sometimes impossible -- to treat, according to Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. "Extensively ...More
    March 10, 2008 Posted in News, Disinfection & Sterilization
  • Hospital Testing for Drug-Resistant Infections Dramatically Lowers Mortality Rates and Costs
    WASHINGTON -- Testing hospitalized patients for drug-resistant infections can reduce mortality, decrease length of stay and reduce cost of care, according to a new report released today by AdvaMed, the Advanced Medical Technology Association. The report describes how ...More
    March 5, 2008 Posted in News
  • CaviWipes Take Surface Disinfection to a New Level
    ORANGE, Calif. -- Metrex Research Corporation announces the newest member of its surface disinfection line, CaviWipes in a flat pack. Its unique patented design offers a new easy-open/easy-close pull tab with slim, flexible packaging and adhesive-backed strips. Each flat ...More
    March 3, 2008 Posted in News
  • New Survey Reveals Highest Rates of Drug-Resistant TB to Date
    WASHINGTON, D.C. and GENEVA -- Multidrug-resistant tuberculosis (MDR-TB) has been recorded at the highest rates ever, according to a new report published today. The report presents findings from the largest survey to date on the scale of drug resistance in tuberculosis. The ...More
    February 27, 2008 Posted in News
  • Efforts to Eliminate Tuberculosis in U.S. by 2010 Fall Far Short of Benchmarks
    The U.S. is likely to fall far short of its benchmark goals toward eliminating tuberculosis as a public health problem, according to data from a nationwide survey. Latent TB infection (LTBI) prevalence in the 1999-2000 U.S. population (excluding homeless and incarcerated ...More
    February 1, 2008 Posted in News
  • Aggressive TB Control Can Yield Big Economic Gains, Says New Study
    WASHINGTON, D.C. -- A new World Bank research report finds that 22 countries with the world’s highest numbers of tuberculosis (TB) cases could earn significantly more than they spend on TB diagnosis and treatment if they signed onto a global plan to sharply reduce the ...More
    January 8, 2008 Posted in News
  • New Drug Targets May Fight Tuberculosis, Bacterial Infections in Novel Way
    Over the course of the 20th century, doctors waged war against infectious bacterial illness with the best new weapon they had: antibiotics. But the emergence of dangerous, multi-drug resistant strains of tuberculosis and other killer infections means that in the 21st ...More
    December 31, 2007 Posted in News
  • Seeking Clues to How Tuberculosis Infects Cells
    Cornell researchers are using advanced genetic techniques to better understand the relationship between the bacteria that cause tuberculosis and the human immune system defense cells that engulf them. The researchers have discovered that unlike many bacterial pathogens, ...More
    December 31, 2007 Posted in News